Manufacturers now face a rapidly evolving landscape where tariffs can shift overnight—from metals to paper to other key ...

In today’s demanding clinical development environment—marked by complex protocols, tightened budgets, and heightened scrutiny from regulators, payers, and patients—fragmented trial planning puts ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to enhance financial flexibility and ...

AstraZeneca's $2 billion investment in Maryland will expand biologics manufacturing and establish a new clinical-stage ...

Abbott's deal shakes up cancer diagnostics, new research confirms pandemic fatigue's impact on public compliance, and more in ...